{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:38:07Z","timestamp":1783593487034,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014489","name":"Johnson &amp; Johnson Pharmaceutical Research and Development LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","award":["TYH2023336"],"award-info":[{"award-number":["TYH2023336"]}],"id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.xagr.2025.100544","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T22:37:08Z","timestamp":1752619028000},"page":"100544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical characteristics and outcomes of pregnancies at-risk of hemolytic disease of the fetus and newborn in Sweden, Finland, and Denmark: a population-based register study"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2305-8101","authenticated-orcid":false,"given":"Kelvin H.M.","family":"Kwok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette \u00d8.","family":"Thunbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Lee","family":"Tjoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Almgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedran","family":"Stefanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Wikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xagr.2025.100544_bib0001","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0887-7963(88)70039-5","article-title":"The prevention of Rh immunization","volume":"2","author":"Bowman","year":"1988","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.xagr.2025.100544_bib0002","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"Delaney","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.xagr.2025.100544_bib0003","first-page":"1","article-title":"Hemolytic disorders of the newborn, current methods of diagnosis and treatment: a review study","volume":"3","author":"Aj","year":"2016","journal-title":"HBTD"},{"issue":"12","key":"10.1016\/j.xagr.2025.100544_bib0004","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/trf.17570","article-title":"How do we perform intrauterine transfusions?","volume":"63","author":"Crowe","year":"2023","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.xagr.2025.100544_bib0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000518782","article-title":"Laboratory monitoring of mother, fetus, and newborn in hemolytic disease of fetus and newborn","volume":"48","author":"Dziegiel","year":"2021","journal-title":"Transfus Med Hemother"},{"issue":"1","key":"10.1016\/j.xagr.2025.100544_bib0006","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1186\/s12884-023-06061-y","article-title":"Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes","volume":"23","author":"de Winter","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.xagr.2025.100544_bib0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12884-022-05329-z","article-title":"Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape","volume":"23","author":"de Winter","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"10.1016\/j.xagr.2025.100544_bib0008","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1471-0528.2009.02244.x","article-title":"Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis","volume":"116","author":"Koelewijn","year":"2009","journal-title":"BJOG: Int J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.xagr.2025.100544_bib0009","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-0528.2008.01984.x","article-title":"Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy","volume":"116","author":"Koelewijn","year":"2009","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.xagr.2025.100544_bib0010","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1537-2995.2010.03006.x","article-title":"Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME)","volume":"51","author":"Dajak","year":"2011","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.xagr.2025.100544_bib0011","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/aogs.12193","article-title":"Consequences of being rhesus D immunized during pregnancy and how to optimize new prevention strategies","volume":"92","author":"Tiblad","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.xagr.2025.100544_bib0012","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.semperi.2008.10.005","article-title":"Disorders of the feto-maternal unit: hematologic manifestations in the fetus and neonate","volume":"33","author":"Black","year":"2009","journal-title":"Semin Perinatol"},{"issue":"4","key":"10.1016\/j.xagr.2025.100544_bib0013","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/ije\/dyu079","article-title":"Associations of rhesus and non-rhesus maternal red blood cell alloimmunization with stillbirth and preterm birth","volume":"43","author":"Fan","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.xagr.2025.100544_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/aogs.12590","article-title":"Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study","volume":"94","author":"Sainio","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.xagr.2025.100544_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2005.04.007","article-title":"Pregnancy outcome for Rh-alloimmunized women","volume":"90","author":"Nardozza","year":"2005","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.xagr.2025.100544_bib0016","article-title":"Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010","volume":"3","author":"Yu","year":"2023","journal-title":"AJOG Glob Rep"},{"key":"10.1016\/j.xagr.2025.100544_bib0017","unstructured":"Svensk f\u00f6rening f\u00f6r obstetrik och gynekologi arbets- och referensgrupp f\u00f6r perinatologi. Graviditetsimmunisering. Accessed August 15, 2024.https:\/\/www.sfog.se\/natupplaga\/web_arg-r5c8f218f-6341-4eeb-a5ee-0c3f3ec06f6a.pdf"},{"issue":"4","key":"10.1016\/j.xagr.2025.100544_bib0018","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/17474086.2017.1305265","article-title":"Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn\u2014review on current management and outcome","volume":"10","author":"Zwiers","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.xagr.2025.100544_bib0019","unstructured":"Verweiij E. Management and outcomes in hemolytic disease of the fetus and newborn: a systematic literature review. Accessed August 15, 2024. https:\/\/www.fetalmedicine.org\/abstracts\/2024\/var\/pdf\/abstracts\/2024\/06314.pdf"},{"issue":"2","key":"10.1016\/j.xagr.2025.100544_bib0020","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2011.09.024","article-title":"Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus\/newborn: the LOTUS study","volume":"206","author":"Lindenburg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2025.100544_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.earlhumdev.2021.105381","article-title":"School performance and behavioral functioning in children after intrauterine transfusions for hemolytic disease of the fetus and newborn","volume":"157","author":"Ree","year":"2021","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.xagr.2025.100544_bib0022","article-title":"Association of autism spectrum disorders with neonatal hyperbilirubinemia","volume":"2","author":"Lozada","year":"2015","journal-title":"Glob Pediatr Health"},{"issue":"4","key":"10.1016\/j.xagr.2025.100544_bib0023","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1537-2995.2011.03362.x","article-title":"Report of the first nationally implemented clinical routine screening for fetal RHD in D-pregnant women to ascertain the requirement for antenatal RhD prophylaxis","volume":"52","author":"Clausen","year":"2012","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.xagr.2025.100544_bib0024","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/aogs.13191","article-title":"Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women\u2014outcome of the first two years of a national program in Finland","volume":"96","author":"Haimila","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2 Pt 1","key":"10.1016\/j.xagr.2025.100544_bib0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/AOG.0b013e31825d33d9","article-title":"Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy","volume":"120","author":"Wikman","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.xagr.2025.100544_bib0026","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/aogs.12917","article-title":"Towards a new era in fetal medicine in the Nordic countries","volume":"95","author":"Sitras","year":"2016","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577825001054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577825001054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:19:23Z","timestamp":1777637963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577825001054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2666577825001054"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2025.100544","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and outcomes of pregnancies at-risk of hemolytic disease of the fetus and newborn in Sweden, Finland, and Denmark: a population-based register study","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2025.100544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100544"}}